Makena Accelerated Approval Hearing Will Be Virtual, Likely In September Or October

Presiding officer Celia Witten denies Covis’ request for an in-person hearing, saying it is unclear at this time how COVID would affect a proceeding in the fall. Hearing agenda spans two-and-a-half days and is modeled, in part, on the Avastin hearing, but with twice the time for public comment.

Calendar
The Makena hearing is expected to take place over two-and-a-half days in the fall. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers